quinapril [Ligand Id: 6350] activity data from GtoPdb and ChEMBL

Click here for a description of the charts and data table

Please tell us if you are using this feature and what you think!

ChEMBL ligand: CHEMBL1592 (C09AA06, CI-906, Quinapril)
  • Angiotensin-converting enzyme in Human [ChEMBL: CHEMBL1808] [GtoPdb: 1613] [UniProtKB: P12821]
  • Angiotensin-converting enzyme in Rabbit [ChEMBL: CHEMBL4074] [UniProtKB: P12822]
  • Angiotensin-converting enzyme in Guinea pig [GtoPdb: 1613]
There should be some charts here, you may need to enable JavaScript!
DB Assay description Assay Type Standard value Standard parameter Original value Original units Original parameter Reference
Angiotensin-converting enzyme in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1808] [GtoPdb: 1613] [UniProtKB: P12821]
ChEMBL Compound was tested for its inhibitory potency against angiotensin I converting enzyme. B 8.08 pIC50 8.3 nM IC50 J Med Chem (1991) 34: 511-517 [PMID:1995872]
ChEMBL Inhibition of guinea pig angiotensin I converting enzyme B 8.08 pIC50 8.3 nM IC50 J Med Chem (1986) 29: 1953-1961 [PMID:3020249]
ChEMBL Inhibitory activity against angiotensin I converting enzyme (ACE) B 8.08 pIC50 8.3 nM IC50 J Med Chem (2000) 43: 305-341 [PMID:10669559]
ChEMBL In vitro inhibitory activity against Angiotensin I converting enzyme from unpurified guinea pig serum B 8.08 pIC50 8.3 nM IC50 J Med Chem (1985) 28: 1291-1295 [PMID:2993618]
Angiotensin-converting enzyme in Rabbit (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4074] [UniProtKB: P12822]
ChEMBL DRUGMATRIX: Peptidase, Angiotensin Converting Enzyme enzyme inhibition (substrate: FAPGG) B 5.4 pIC50 4008 nM IC50 DrugMatrix in vitro pharmacology data
ChEMBL Inhibition of rabbit lung ACE assessed as hippuryl-histidyl-leucine hydrolysis after 30 mins by colorimetric method B 6.96 pIC50 110 nM IC50 Bioorg Med Chem (2015) 23: 3526-3533 [PMID:25922179]
Angiotensin-converting enzyme in Guinea pig [GtoPdb: 1613]
GtoPdb - - 8.1 pIC50 8.3 nM IC50 Fed Proc (1984) 43: 1326-9 [PMID:6323223]

ChEMBL data shown on this page come from version 34:

Zdrazil B, Felix E, Hunter F, Manners EJ, Blackshaw J, Corbett S, de Veij M, Ioannidis H, Lopez DM, Mosquera JF, Magarinos MP, Bosc N, Arcila R, Kizilören T, Gaulton A, Bento AP, Adasme MF, Monecke P, Landrum GA, Leach AR. (2024). The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Res., 52(D1). DOI: 10.1093/nar/gkad1004. [EPMCID:10767899] [PMID:37933841]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]